Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
REGENXBIO Inc. (RGNX) Debt to Equity Ratio data is not available for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$30.34M |
|
$-67.15M |
|
$5.93M |
|
$24.41M |
|
$87.97M |
|
$-57.64M |
|
$-9.51M |
|
$-67.15M |
|
$-67.15M |
|
$-67.15M |
|
$-67.15M |
|
$-67.15M |
|
$-67.15M |
|
$-57.64M |
|
$-53.77M |
|
51.57M |
|
51.57M |
|
$-1.30 |
|
$-1.30 |
|
| Balance Sheet Financials | |
$281.28M |
|
$104.86M |
|
$171.75M |
|
$453.03M |
|
$118.09M |
|
-- |
|
$232.20M |
|
$350.30M |
|
$102.73M |
|
$102.73M |
|
$102.73M |
|
50.89M |
|
| Cash Flow Statement Financials | |
$-123.96M |
|
$-15.87M |
|
$116.77M |
|
$59.56M |
|
$36.50M |
|
$-23.06M |
|
$34.56M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.38 |
|
-- |
|
-- |
|
-- |
|
|
Debt to Equity Ratio |
-- |
80.46% |
|
-189.99% |
|
-189.99% |
|
-- |
|
-221.34% |
|
-221.34% |
|
$-126.38M |
|
-- |
|
-- |
|
-- |
|
0.07 |
|
-- |
|
1.15 |
|
78.26 |
|
-65.36% |
|
-65.36% |
|
-14.82% |
|
-65.36% |
|
$2.02 |
|
$-2.45 |
|
$-2.40 |
|